Literature DB >> 34406429

Exercise Recommendations in Pediatric HCM: Variation and Influence of Provider Characteristics.

Robert D Whitehill1,2, Seshadri Balaji3, Michael Kelleman4,5, Stephanie F Chandler6, Dominic J Abrams7, Chad Mao4,5, Peter Fischbach4,5, Robert Campbell4,5.   

Abstract

Pediatric Hypertrophic Cardiomyopathy (HCM) is associated with sudden cardiac death (SCD) that can be related to physical activity. Without pediatric specific guidelines, recommendations for activity restriction may be varied. Therefore, our aim is to determine the current practice and variability surrounding exercise clearance recommendations (ER) in pediatric HCM referral centers as well as provider and patient characteristics that influence them. We designed a survey that was distributed to the Pediatric Heart Transplant Study (PHTS) providers and members of the Pediatric and Adult Congenital Electrophysiology Society (PACES) querying provider demographics and patient variables from 2 patient vignettes. The study is a multicenter survey of current practice of specialized providers caring for pediatric HCM patients. Survey of PHTS and PACES providers via email to the respective listservs with a response rate of 28% and 91 overall completing the entire survey after self-identifying as providers for pediatric HCM patients at their center. ER varies for pediatric HCM and is associated with provider training background as well as personal and professional history. Of the 91 providers who completed the survey, 42% (N = 38) trained in pediatric electrophysiology (EP), and 40% (N = 36) in pediatric heart failure (HF). Responses varied and only 53% of providers cleared for mild to moderate activity for the patient in Vignette 1, which is more in line with recent published adult guidelines. ER in both vignettes was significantly associated with type of training background. EP providers were more likely to recommend no restriction (27.8% vs 5.9%) than HF providers even when controlling for provider age and time out of training. Syncope with exercise was deemed "Most Important" by 81% of providers when making ER. ER for pediatric HCM are variable and the majority of providers make ER outside of previously published adult guidelines. Furthermore, ER are influenced by provider background and experience. Further study is needed for risks and benefits of physical activity in this population to inform the development of pediatric specific guidelines.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Year:  2021        PMID: 34406429     DOI: 10.1007/s00246-021-02703-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  33 in total

1.  Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy.

Authors:  Juan Pablo Kaski; María Teresa Tomé Esteban; Martin Lowe; Simon Sporton; Philip Rees; John E Deanfield; William J McKenna; Perry M Elliott
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

Review 2.  Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

Authors:  Barry J Maron; Steve R Ommen; Christopher Semsarian; Paolo Spirito; Iacopo Olivotto; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

3.  Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.

Authors:  Seshadri Balaji; Michael P DiLorenzo; Frank A Fish; Susan P Etheridge; Peter F Aziz; Mark W Russell; Svjetlana Tisma; Andreas Pflaumer; Narayanswami Sreeram; Peter Kubus; Ian H Law; Michal J Kantoch; Naomi J Kertesz; Margaret Strieper; Christopher C Erickson; Jeremy P Moore; Stephanie J Nakano; Harinder R Singh; Philip Chang; Mitchell Cohen; Anne Fournier; Maria V Ilina; Richard T Smith; Frank Zimmerman; Michaela Horndasch; Walter Li; Anjan Batra; Leonardo Liberman; Robert Hamilton; Christopher M Janson; Shubhayan Sanatani; Ilana Zeltser; George McDaniel; Andrew D Blaufox; Jason M Garnreiter; Hannah Katcoff; Maully Shah
Journal:  Heart Rhythm       Date:  2019-04-23       Impact factor: 6.343

4.  Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results From a National Population-Based Study.

Authors:  Peta M A Alexander; Alan W Nugent; Piers E F Daubeney; Katherine J Lee; Lynn A Sleeper; Tibor Schuster; Christian Turner; Andrew M Davis; Chris Semsarian; Steven D Colan; Terry Robertson; James Ramsay; Robert Justo; Gary F Sholler; Ingrid King; Robert G Weintraub
Journal:  Circulation       Date:  2018-02-28       Impact factor: 29.690

5.  Incidence and causes of sudden death in U.S. college athletes.

Authors:  Barry J Maron; Tammy S Haas; Caleb J Murphy; Aneesha Ahluwalia; Stephanie Rutten-Ramos
Journal:  J Am Coll Cardiol       Date:  2014-02-26       Impact factor: 24.094

6.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

7.  A Prospective Study of Sudden Cardiac Death among Children and Young Adults.

Authors:  Richard D Bagnall; Robert G Weintraub; Jodie Ingles; Johan Duflou; Laura Yeates; Lien Lam; Andrew M Davis; Tina Thompson; Vanessa Connell; Jennie Wallace; Charles Naylor; Jackie Crawford; Donald R Love; Lavinia Hallam; Jodi White; Christopher Lawrence; Matthew Lynch; Natalie Morgan; Paul James; Desirée du Sart; Rajesh Puranik; Neil Langlois; Jitendra Vohra; Ingrid Winship; John Atherton; Julie McGaughran; Jonathan R Skinner; Christopher Semsarian
Journal:  N Engl J Med       Date:  2016-06-23       Impact factor: 91.245

8.  Hypertrophic Cardiomyopathy as a Cause of Sudden Cardiac Death in the Young: A Meta-Analysis.

Authors:  Aditya J Ullal; Ramy S Abdelfattah; Euan A Ashley; Victor F Froelicher
Journal:  Am J Med       Date:  2016-01-20       Impact factor: 4.965

9.  Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Michael J Ackerman; Susan A Casey; Christopher Semsarian; N A Mark Estes; Kevin M Shannon; Euan A Ashley; Sharlene M Day; Giuseppe Pacileo; Francesco Formisano; Emmanuela Devoto; Aristidis Anastasakis; J Martijn Bos; Anna Woo; Camillo Autore; Robert H Pass; Giuseppe Boriani; Ross F Garberich; Adrian K Almquist; Mark W Russell; Luca Boni; Stuart Berger; Martin S Maron; Mark S Link
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094

10.  Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry.

Authors:  Barry J Maron; Tammy S Haas; Aneesha Ahluwalia; Caleb J Murphy; Ross F Garberich
Journal:  Am J Med       Date:  2016-04-01       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.